跳至主要内容
临床试验/NCT03966339
NCT03966339Unknown不适用

Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality:a Randomized Controlled Study

Reproductive & Genetic Hospital of CITIC-Xiangya1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2019年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
128
试验地点
1
主要终点
proportion of high-quality embryos at D3

研究概览

简要总结

GH plays an important role in the synthesis of ovarian steroid hormone and follicular development as a paracrine hormone.GH can regulate the growth hormone receptor and strengthen the function of mitochondria to improve the quality of the female oocyte.In this study, a prospective randomized control was used to explore the effect of GH adjuvant therapy on embryo quality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • infertility women whose age ≥20 and ≤39 years old; 2)women has done IVF/ICSI assisted treatment ≥1 times; 3)number of IVF/ICSI assisted treatment cylces with ≥6 oocytes retrieved ≥1; 4)number of IVF/ICSI assisted treatment cylces with ≥50% fertilization rate ≥1 ; 5)historical assisted reproduction cycles without ≥6C-Ⅱ level embryos at the third day after oocytes retrieval or without blastocyst formation after blastocyst culturing.

排除标准

  • Diseases related to IVF treatment outcome, such as untreated hydrosalpinx, uterine fibroids affecting uterine cavity, myometriosis, endometrial lesions, obvious uterine abnormalities,etc; 2)Severe acute or chronic liver or kidney diseases, such as cirrhosis, acute or chronic renal failure, hepatitis B virus activity period,etc.;in patients with abnormal liver and kidney function, the AST or ALT detection value was 2.5 times higher than the upper limit of normal, and the serum creatinine was 2 times higher than the upper limit of normal.
  • Endocrine and metabolic diseases and adrenal diseases, such as diabetes, Cushing's syndrome,etc.; 4)People has allergy history of growth hormone product; 5)Participating in other clinical research; 6)Other conditions that researchers determined not fit to be enrolled.

研究组 & 干预措施

GH group

Experimental

Growth Hormone adding to controlled ovarian hyperstimulation

干预措施: Growth hormone (Drug)

结局指标

主要结局

proportion of high-quality embryos at D3

时间窗: the third day after oocyte retrieval

proportion of embryos grading 6C-II and above 6C-II at the third day after oocyte retrieval

number of high-quality embryos at D3

时间窗: the third day after oocyte retrieval

number of embryos grading 6C-II and above 6C-II at the third day after oocyte retrieval

次要结局

  • number of high-quality oocytes(four months)
  • total days of Gn used(two months)
  • E2 levels at triggering day(four months)
  • clinical pregnancy rate(28 days after embryo transplanted)
  • total amount of Gn used(four months)
  • implantation rate(28 days after embryo transplanted)
  • IGF-I level at the first day of injecting Gn and before injecting Gn(at the first day of injecting Gn and before injecting Gn)
  • IGF-I level at triggering day(four months)
  • number of blastocysts at the fifth,sixth or seventh day after oocyte retrieval(at the fifth,sixth or seventh day after oocyte retrieval)
  • IGF-I level at the first day of injecting GH and befor injecting GH(GH group)(at the first day of injecting GH and befor injecting GH(GH group))

研究者

发起方
Reproductive & Genetic Hospital of CITIC-Xiangya
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Growth Hormone Adding to Controlled Ovarian... | 临床试验